CA2541398C - Liquid formulations of ractopamine - Google Patents

Liquid formulations of ractopamine Download PDF

Info

Publication number
CA2541398C
CA2541398C CA2541398A CA2541398A CA2541398C CA 2541398 C CA2541398 C CA 2541398C CA 2541398 A CA2541398 A CA 2541398A CA 2541398 A CA2541398 A CA 2541398A CA 2541398 C CA2541398 C CA 2541398C
Authority
CA
Canada
Prior art keywords
ractopamine
solubilized
formulation
water
stabilized liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2541398A
Other languages
English (en)
French (fr)
Other versions
CA2541398A1 (en
Inventor
Michael David Senior Burton
Paul Reuben Klink
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of CA2541398A1 publication Critical patent/CA2541398A1/en
Application granted granted Critical
Publication of CA2541398C publication Critical patent/CA2541398C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/111Aromatic compounds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K40/00Shaping or working-up of animal feeding-stuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/10Feeding-stuffs specially adapted for particular animals for ruminants
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/30Feeding-stuffs specially adapted for particular animals for swines
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/70Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75Feeding-stuffs specially adapted for particular animals for birds for poultry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Birds (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
CA2541398A 2003-10-07 2004-10-04 Liquid formulations of ractopamine Expired - Lifetime CA2541398C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50934803P 2003-10-07 2003-10-07
US60/509,348 2003-10-07
PCT/US2004/030902 WO2005036980A1 (en) 2003-10-07 2004-10-04 Liquid formulations of ractopamine

Publications (2)

Publication Number Publication Date
CA2541398A1 CA2541398A1 (en) 2005-04-28
CA2541398C true CA2541398C (en) 2012-08-21

Family

ID=34465105

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2541398A Expired - Lifetime CA2541398C (en) 2003-10-07 2004-10-04 Liquid formulations of ractopamine

Country Status (5)

Country Link
US (1) US7943670B2 (https=)
EP (1) EP1672985A1 (https=)
JP (1) JP2007507226A (https=)
CA (1) CA2541398C (https=)
WO (1) WO2005036980A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8309603B2 (en) * 2004-06-07 2012-11-13 University Of Tennessee Research Foundation SARMs and method of use thereof
WO2007143336A2 (en) * 2006-05-30 2007-12-13 Stirling Products Limited Use of ractopamine enantiomers
US9730908B2 (en) 2006-08-24 2017-08-15 University Of Tennessee Research Foundation SARMs and method of use thereof
US9844528B2 (en) 2006-08-24 2017-12-19 University Of Tennessee Research Foundation SARMs and method of use thereof
US10010521B2 (en) 2006-08-24 2018-07-03 University Of Tennessee Research Foundation SARMs and method of use thereof
KR20080076667A (ko) * 2007-02-15 2008-08-20 주식회사 중외제약 요변성 약학 조성물
AU2017408659B2 (en) * 2017-04-04 2019-12-19 Hermann Roth Animal feed with beta adrenergic agonist and isoquinoline alkaloid
EP3488705A1 (en) * 2017-11-23 2019-05-29 Saviela AG Solubilized growth promoting product to be applied orally to animals and method for the respective feed preparation
CN117180187B (zh) * 2023-08-18 2024-04-26 亚邦医药股份有限公司 一种盐酸多巴胺注射液的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1145766A (en) * 1978-07-03 1983-05-03 Jack Mills Optically active phenethanolamines and method for increasing cardiac contractility
DK171627B1 (da) * 1983-01-31 1997-03-03 Lilly Co Eli Anvendelse af beta-phenethanolamin og farmaceutiskacceptable salte deraf samt dyrefoderpræblanding med indhold deraf
US4690951A (en) * 1983-01-31 1987-09-01 Eli Lilly And Company Growth promotion
US5308870A (en) * 1992-12-21 1994-05-03 Eli Lilly And Company Ractopamine for pre-and peripubertal female bovidae
SI0989851T1 (en) * 1997-07-29 2003-04-30 Pharmacia & Upjohn Company Self-emulsifying formulation for acidic lipophilic compounds
AUPQ981700A0 (en) * 2000-09-01 2000-09-28 Metabolic Pharmaceuticals Limited Product and method for control of obesity

Also Published As

Publication number Publication date
JP2007507226A (ja) 2007-03-29
US7943670B2 (en) 2011-05-17
CA2541398A1 (en) 2005-04-28
EP1672985A1 (en) 2006-06-28
US20070042022A1 (en) 2007-02-22
WO2005036980A1 (en) 2005-04-28

Similar Documents

Publication Publication Date Title
CN1082346C (zh) 动物饲料添加剂和含有该添加剂的饲料
US9040571B2 (en) Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system
US20080032021A1 (en) Feed supplements for ruminants including essential oil compounds and organic acids
US20110021461A1 (en) Combinations to improve animal health and performance
US8580772B2 (en) Combination therapies using melengestrol acetate and zilpaterol or its salts
CA2541398C (en) Liquid formulations of ractopamine
JPS6348223A (ja) 非経口投与のための組成物及びその使用
US4792546A (en) Method for increasing weight gains and reducing deposition of fat in animals
EP0146738A2 (en) Antimicrobial animal feed additive compositions
NZ272574A (en) Aqueous base suspension concentrate containing at least one ionophore antibiotic and wetting agent and/or a surfactant and xanthan gum optionally with a suspension agent, an antifreeze agent and an antifoaming agent; drench for veterinary treatment
KR20000035832A (ko) 살균성 조성물
AU2020249679B2 (en) Pregabalin formulations and use thereof
JPH0829051B2 (ja) 動物用製剤
JP2011182748A (ja) 家畜又は家禽用飼料
EP1299124B1 (en) Composition for aqueous stabilization of fat-soluble vitamins
WO2019101921A1 (en) Solubilized growth promoting product to be applied orally to animals and method for the respective feed preparation
AU2002216750A1 (en) Composition for aqueous stabilization of fat-soluble vitamins
EP0166025A2 (en) Non-antibiotic animal feed additive compositions
HU203040B (en) Process for producing weight-increasing composition containing 1-(3,5-dihydroxy-phenyl)-2-(terc-butyl-amino)-ethanol
US20140171497A1 (en) Animal supplements and compositions containing soluable monensin and methods therefor
MX2010006808A (es) Formulacion inyectable de un antiparasitario combinado con un promotor de crecimiento.
CN103702570A (zh) 含有可溶性莫能菌素组合物的动物补充品和食物组合物及其使用方法和制备方法

Legal Events

Date Code Title Description
EEER Examination request